Abstract. Over 2 million Americans are currently living with prostate cancer. Current chemotherapeutic strategies are only partially effective in controlling the disease. There is always a need for an effective newer drug for treating prostate cancer. Use of active principles from medically important herbs has proven to be effective in treating various forms of cancers. Glycyrrhizin, a triterpene compound isolated from roots of licorice has been found to exhibit potent in vitro cytotoxic activity against several human cancer cell lines. In this study, we evaluated the effects of glycyrrhizin on the viability of two human prostate cancer cells LNCaP (hormone-dependent) and DU-145 (hormone-independent) in vitro. Cell viability assay showed that glycyrrhizin inhibited the cell proliferation of prostate cancer cells in a time-and dose-dependent manner. The decreased viability of prostate cancer cells was due to apoptosis as confirmed by Annexin-V FITC flow cytometric analyses. Glycyrrhizin also caused DNA damage in DU-145 and LNCaP cells in a time-dependent manner. Caspase-3 and -8 activities were not detected in glycyrrhizin-treated prostate cancer cells suggesting that caspase-independent pathways may be involved in the apoptotic mechanism. Collectively, these studies suggest that glycyrrhizin has therapeutic potential against prostate cancer.
Introduction
Prostate cancer is the most common non-cutaneous cancer, with approximately 218,890 expected new cases and 27,050 deaths in the year 2007 in American men (1) . It is the second most common cancer in men after lung cancer and prostate cancer incidence continue to increase every year. Although causes of prostate cancer remain obscure, there are several risk factors such as race, increasing age, and a family history that are significant risk factors for the development of prostate cancer (2) . In the initial stages, prostate cancer can be treated by androgen-ablative therapy, surgery, radiotherapy or radical prostatectomy (3) . Patients who respond to these therapies eventually fail to respond as the disease progresses and succumb to the disease because of the development of androgen-independent prostate cancer that progress into metastasis. Chemotherapy is the primary treatment for most types of metastatic cancer. However, conventional chemotherapeutic agents are often inadequate due to enhanced malignancy and multidrug-resistance by cancer cells. Therefore, development of effective chemotherapeutic agents is needed to control the metastatic stages of prostate cancer, which would enormously improve life expectancy of the patient.
Many dietary supplements and plant-derived products are shown to be promising anti-tumor therapeutic agents and are now being assessed in pre-clinical and clinical studies (4, 5) . These anti-tumor agents usually activate the apoptosis pathways in tumor cells. Glycyrrhizin, a triterpenoid saponin isolated from licorice root, induce apoptosis in many cell types including human hepatoma (HLE), promyelotic leukemia (HL-60) and stomach cancer (KATO III) and Kaposi sarcomaassociated herpesvirus-infected cells (6, 7) . Glycyrrhizininduced apoptosis causes DNA fragmentation and oxidative stress in cancer cells (6, 7) . In addition to the anti-tumor effect, glycyrrhizin also has several bioactivities (8, 9) . Some of these include chemotherapeutic activity in chronic hepatitis (8) and as an antiviral agent against HIV-1, SARS-related coronavirus, respiratory syncytial virus, arboviruses, vaccinia virus and vesicular stomatitis virus (9) . Since there are no reports on the effects of glycyrrhizin on prostate cancer, in the current study we examined the effect of glycyrrhizin on two different prostate cancer cell lines LNCaP (androgendependent) and DU-145 (androgen-independent). Antiproliferative responses of glycyrrhizin on these cell lines and its potential to induce apoptosis were evaluated.
Materials and methods

Chemicals and reagents.
Fetal calf serum (FCS), RPMI-1640 and minimum essential medium (MEM) were obtained from American Type Cell Culture (ATCC), Manasas, VA. Glycyrrhizin was purchased from Sigma-Aldrich (St. Louis, MO). The structure of glycyrrhizin [3- Fig. 1 5 cells/ml were seeded and grown for 24 h before experimental treatments. Cells were maintained at 37˚C, 5% CO 2 environment.
Cell viability assay. Cells were treated for different periods of time with different doses of glycyrrhizin (0.1-20 mM). Cell viability was measured using a CCK-8 kit purchased from Dojindo Molecular Technologies Inc. Briefly, cells were cultured in 96-well plates in the presence of 10 μl aliquots of glycyrrhizin at various concentrations ranging from 0.1 to 20 mM. Following exposure to glycyrrhizin, 10 μl of CCK-8 solution was added to each well, and the plates were incubated for 4 h at 37˚C and read immediately at 450 nm using a microplate reader (Bio-Rad, Richmond, CA).
Agarose gel electrophoresis analysis for DNA fragmentation.
LNCaP and DU-145 cells were cultured in 6-well tissue culture plates for 24 h at 37˚C in 5% CO 2 environment. Cells were then exposed to 10 mM glycyrrhizin. At the end of experimental period, cells were collected and suspended in 200 μl of PBS. DNA was isolated using DNA extraction kit (DNeasy blood and tissue kit, Qiagen) as per the manufacturer's recommendations. The purity of DNA was analyzed in a spectrophotometer at 260/280 nm and ratio was confirmed to be between 1.7 and 1.9. DNA samples were then electrophoresed on a 2% agarose gel and visualized with ethidium bromide staining under UV illumination.
Assessment of apoptosis in LNCaP and DU-145 cells by flow cytometry.
Cells were stained with an Annexin V-FITC apoptosis detection kit (MBL) to determine the percentage of apoptotic cells. Propidium iodide staining was used as a control to differentiate cells undergoing necrosis. Cells (6x10 5 ) were seeded in 25-cm 2 flasks and allowed to attach for 24 h. After treating with glycyrrhizin for 72 h, detached and attached cells were collected and washed twice with ice-cold PBS. Subsequently, cells were resuspended in 500 μl of 1X binding buffer, 5 μl Annexin V-FITC and 5 μl of propidium iodide were added and incubated for 5 min at 37˚C in the dark. The number of viable, apoptotic and necrotic cells were quantified by flow cytometer (Becton Dickinson, USA) and data analyzed by CellQuest software.
Caspase activity. Caspase-3 and -8 activities were measured using colorimetric assay kits (R&D Systems). After addition of glycyrrhizin, cells were washed with ice-cold PBS and caspase-3 and -8 activities were determined using the kit following the manufacturer's recommendations. Caspase colorimetric substrates DEVD-pNA (caspase-3) or IETDpNA (caspase-8) were added to the cell lysate and assays were performed in a 100-μl volume in 96-well flat-bottomed plates. Chromophore p-nitroanilide is released as a result of cleavage of substrates by caspase activity. The caspase enzymatic activity in the cell lysate is directly proportional to the chromophore formation, which was quantified spectrophotometrically at a wavelength of 405 nm using a microplate reader. Data were corrected for the background values that had no substrate or no cell lysate treated.
Statistics. Data were compared using the Mann-Whitney rank sum test using the SigmaStat program (Jandel Scientific, San Rafel, CA). P<0.05 was considered statistically significant.
Results
The effect of glycyrrhizin on cell viability. No significant reduction in cell viability was detected when low concentrations of glycyrrhizin (1-2 mM) were added to LNCaP and DU-145 cells. However, an inverse relationship was observed between CCK-8 activity (cell viability) and high concentrations of glycyrrhizin (5-20 mM) especially following 48 and 72 h treatments. With increasing concentration of glycyrrhizin, CCK-8 activity was decreased in LNCaP and DU-145 cells. The ability of glycyrrhizin to decrease CCK-8 activity by 50% [IC 50 ] in LNCaP and DU-145 cells was achieved at concentrations of 8.5 and 12.5 mM respectively after incubation for 48 h (Fig. 2) . Interestingly, glycyrrhizin at a dose of 8.5 mM significantly (P<0.05) reduced the viability of LNCaP cells compared to DU-145 cells at 24, 48 and 72 h time-points. Consistently our results showed that LNCaP cells were more sensitive to glycyrrhizin than DU-145 cells. IC 50 values were significantly decreased when the glycyrrhizin concentration was reduced to 5 mM (in LNCaP cells) and to ~10 mM (in DU-145 cells) respectively following incubation of the cells for 72 h.
Glycyrrhizin induces DNA fragmentation. We examined chromosomal DNA fragmentation to confirm apoptosis in cells. LNCaP and DU-145 cells were treated with 10 mM glycyrrhizin for 48 or 72 h. DNA was isolated and analyzed by agarose gel electrophoresis. As shown in Fig. 3 , glycyrrhizin treatment induced DNA degradation in LNCaP and DU-145 cells suggesting that the cells treated with glycyrrhizin may be undergoing apoptosis.
Caspase-3 and -8 activities.
Since the above studies suggested that glycyrrhizin may be inducing apoptosis in the cancer cell lines, we wanted to determine whether this involved caspase-3 or -8 activities. A chromogenic caspase-3 and -8 substrates was used to directly examine the role of these caspases in glycyrrhizin-treated cells. Results showed that caspase-3 and -8 were not activated in glycrrhizin-treated LNCaP and DU-145 cell lines (P>0.1) compared to untreated controls (Fig. 4) .
Analysis of Annexin V-FITC/PI staining.
Annexin V-FITC assay was used to further confirm glycyrrhizin induced apoptosis in LNCaP and DU-145 cells. Annexin V is a phospholipid-binding protein that has a high affinity for membrane phospholipid phosphatidylserine (PS). During the early stage of apoptosis PS is translocated from the inner leaflet to the outer surface of the plasma membrane (10) . PI staining of DNA occurs due to loss of plasma membrane integrity. Hence, staining with Annexin V-FITC was used in ONCOLOGY REPORTS 20: 1387 -1392 , 2008 combination with propidium iodide to detect apoptotic and necrotic cells. Double staining with Annexin V and propidium iodide will indicate that cells are in the late stage of apoptosis or already dead at this stage.
Results from flow cytometric analysis (Fig. 5 ) also revealed that 10 mM glycyrrhizin treatment for 72 h increased the percentage of Annexin V-stained cells and induced an early apoptotic change in >94% LNCaP cells and ~40% in DU-145 cells. The total apoptotic DU-145 cell population was increased to 63.62% after treatment with glycyrrhizin. The Annexin V and PI double positive DU-145 cells were also significantly increased following glycyrrhizin treatment. In contrast, the cells without glycyrrhizin treatment demonstrated normal cell viability with no remarkable cell death.
Discussion
Natural compounds are widely preferred for treatment of different diseases including cancer as they have minimal side effects. Glycyrrhizin, a natural, biologically active substance isolated from licorice root is shown to have several therapeutic properties including anti-inflammatory (11) anti-viral activity (12, 13) and anti-tumorigenic properties (14, 15) . Glycyrrhizin is a triterpenoid consisting of glycyrrhetinic acid and two iduronic acid residues. Earlier studies showed that glycyrrhizin can induce varying degree of apoptosis in cancer cells depending upon concentrations (2-12 mM) and cell lines used (6, 7, 16, 17) . At a concentration of 12 mM glycyrrhizin induced 100% apoptosis in human stomach cancer KATO III and promyelotic leukemia HL-60 cell lines. Whereas, normal cells from healthy volunteers were found to be resistant to cell growth inhibition and apoptotic induction by glycyrrhizin at least up to the concentration of 12 mM (6,7) suggesting glycyrrhizin is a safe and non-toxic natural product. Results presented in this study support these earlier findings and further show that glycyrrhizin has potential anti-prostate cancer effect.
Cell viability assay in our studies demonstrated that exposure of LNCaP and DU-145 cells to glycyrrhizin significantly decreased the viability of these prostate cancer cells in a time-and dose-dependent manner. Of these two cell lines, LNCaP was more susceptible to glycyrrhizin than DU-145. Mechanism of glycyrrhizin-induced cell death in the prostate cancer cell line appears to be apoptosis as evidenced by Annexin V-PI staining, which identifies early and late apoptotic changes in cells. Our studies also show that LNCaP cells, which are androgen-dependent, appeared to be more susceptible to the apoptotic action of glycyrrhizin, than DU-145 cells that are androgen-independent prostate cancer cells. Understanding the molecular events of tumorigenesis is essential for the development of therapeutic treatments of cancer. Transition from androgen-dependent to androgenindependent stage is associated with increasing resistance to induction of apoptosis in prostate cancer progression (18) . This is the reason why most chemotherapeutic agents fail with androgen-independent prostate cancer cells. In this study, we tested whether glycyrrhizin has apoptotic effect in LNCaP and DU-145 cells. Glycyrrhizin induced higher apoptotic responses in LNCaP cells, although the effect was lower in DU-145 cells.
Glycyrrhizin has the potential to decrease serum androgen levels and bind to androgen receptor (19) (20) (21) (22) . LNCaP cells carry androgen receptors on their surface whereas DU-145 cells do not and yet both cells are susceptible to apoptotic death induced by glycyrrhizin. It is possible that glycyrrhizin might be inducing apoptosis by distinct mechanisms in these two cell lines.
Another possible reason is that the tumor suppressor gene p53 is mutated in DU-145 cells (23) . This might explain the reduced cytotoxic effect of glycyrrhizin on DU-145. A study conducted by Curreli et al (16) showed that glycyrrhizin can induce p53-mediated apoptosis in KSHV-infected B lymphocytes suggesting that the status of p53 may be important for the cytotoxic function of glycyrrhizin. Since the mechanism of cell death following glycyrrhizin appears to be apoptotic, we evaluated whether caspasedependent pathways are activated following treatment with glycyrrhizin. Our results showed that glycyyrhizin did not activate caspase-3 or -8 in LNCaP and DU-145 cells. This observation support previous studies where glycyrrhizin failed to induce caspase activity in HLE and KATO III cells, yet was able to induce apoptosis in these cells (7) . These results thus suggest that glycyrrhizin potentially trigger a caspaseindependent apoptotic pathway in its target cells. Studies by Curreli et al showed that four days after treatment with glycyrrhizin, there was translocation of apoptosis-inducing factor (AIF) to the nucleus of KSHV-infected B cells (16) . AIF is released by the mitochondria in disparity to cytochrome c and activates caspase-independent apoptosis pathway. AIF is a mitochondrial intermembrane flavoprotein with oxidoreductase that induces chromatin condensation and DNA fragmentation (24-26). Although we did not study the translocation of AIF, we did observe DNA fragmentation in LNCaP and DU-145 cell lines when exposed to glycyrrhizin, thus confirming that apoptosis resulting from exposure to glycyrrhizin in LNCaP and DU-145 cells is possibly via the caspase-independent pathway.
The current study thus provides evidence of an antitumorigenic activity for glycyrrhizin against prostate cancer cells. Androgen-dependent LNCaP cells appeared to be more vulnerable to glycyrrhizin treatment compared to androgenindependent DU-145 cells. Nevertheless, glycyrrhizin treatment induced apoptosis in both cell lines. Glycyrrhizin-induced apoptosis appears to be not mediated by caspase activation. These findings suggest that glycyrrhizin has the potential as a therapeutic agent against prostate cancer. Further studies are needed to evaluate the mechanism of apoptosis induced by glycyrrhizin in prostate cancer cells and its ability to kill prostate cancer cells in vivo.
